Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

This study has been completed.
Information provided by (Responsible Party):
Clavis Pharma Identifier:
First received: November 29, 2006
Last updated: September 12, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 12, 2013